Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Seizures With Secondary Generalization”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT01830868
What this trial is testing

A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)

Who this might be right for
Partial Onset Seizures
Eisai Inc. 104
Not applicableStudy completedNCT01532726
What this trial is testing

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

Who this might be right for
Epilepsy
Bial - Portela C S.A. 56
Large-scale testing (Phase 3)Study completedNCT03250377
What this trial is testing

Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Who this might be right for
Partial Seizures With or Without Secondary GeneralizationEpilepsy
UCB Biopharma SRL 207
Not applicableStudy completedNCT02687711
What this trial is testing

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures

Who this might be right for
Epilepsy With POS With or Without Secondary Generalization
UCB Biopharma S.P.R.L. 544
Testing effectiveness (Phase 2)Ended earlyNCT04529954
What this trial is testing

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

Who this might be right for
Focal Epilepsy
Cerebral Therapeutics LLC 20
Post-approval studies (Phase 4)Study completedNCT02726074
What this trial is testing

Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

Who this might be right for
Epilepsy
Eisai Korea Inc. 106
Not applicableStudy completedNCT01673282
What this trial is testing

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy

Who this might be right for
Focal Epilepsy With and Without Secondary Generalization
UCB Pharma GmbH 315
Testing effectiveness (Phase 2)Study completedNCT00800215
What this trial is testing

A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927

Who this might be right for
Epilepsy
UCB Pharma 60
Large-scale testing (Phase 3)Study completedNCT02192814
What this trial is testing

Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Japan Co. Ltd. 9
Large-scale testing (Phase 3)Study completedNCT01749046
What this trial is testing

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Who this might be right for
EpilepsySimple Partial SeizuresComplex Partial Seizures+1 more
Valexfarm 224
Large-scale testing (Phase 3)Ended earlyNCT00698581
What this trial is testing

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 88
Large-scale testing (Phase 3)Study completedNCT01710657
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures

Who this might be right for
EpilepsyPartial Onset Seizures
UCB Pharma SA 548
Large-scale testing (Phase 3)Study completedNCT02124564
What this trial is testing

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Japan Co. Ltd. 19
Post-approval studies (Phase 4)Looking for participantsNCT06967012
What this trial is testing

A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures

Who this might be right for
Epilepsies, PartialEpilepsy, Tonic-Clonic
Affiliated Hospital of Nantong University 30
Large-scale testing (Phase 3)Study completedNCT01832038
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Pharma SA 473
Not applicableStudy completedNCT04252846
What this trial is testing

Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Who this might be right for
Idiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures
Eisai Limited 191
Not applicableStudy completedNCT01098162
What this trial is testing

Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug

Who this might be right for
Epilepsies, Partial
UCB Pharma GmbH 576
Large-scale testing (Phase 3)Study completedNCT03083665
What this trial is testing

Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

Who this might be right for
Partial Seizures With or Without Secondary GeneralizationEpilepsy
UCB Biopharma SRL 449
Not applicableStudy completedNCT01620840
What this trial is testing

Lacosamid-i.v.-Register

Who this might be right for
Epilepsy With Partial Onset Seizures With or Without Secondary Generalization
University Hospital Schleswig-Holstein 130
Large-scale testing (Phase 3)Study completedNCT00220415
What this trial is testing

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Who this might be right for
Partial Seizures With or Without Secondary Generalization
UCB Pharma
Load More Results